Prospective X-ray densitometry and ultrasonography study of the hand banes of patients with rheumatoid arthritis of recent onset

Prospective X-ray densitometry and ultrasonography study of the hand banes of patients with rheumatoid arthritis of recent onset
复制标题

DOI:
10.1016/s1297-319x(00)00227-x
复制
发表时间:
2001-02-01
期刊:
影响因子:
4.2
通讯作者:
Le Loët, X
Le Loët, X
中科院分区:
医学2区
文献类型:
--
作者:
Daragon, A;Krzanowska, K;Le Loët, X

文献摘要

被引文献

相似文献

Objective. Bone demineralization observed in early rheumatoid arthritis is not easily measured. To measure bone loss and to discriminate between rheumatoid arthritis and other rheumatic diseases, we used two methods: dual-energy X-ray absorptiometry and ultrasonography. Methods. From a population-based recruitment, 32 patients with early peripheral polyarthritis (median disease duration: 4 months) were studied. Clinical, laboratory, functional, hand-bone assessments were made at the entry and at months 6 and 12. Bone X-ray densitometry measurements were made on 16 areas of the hand. Speed of sound was measured across the proximal phalanges of the four fingers. X-rays of both hands were scored according to the modified Sharp's score. At 12 months, patients were classified as rheumatoid arthritis (N = 15; 9 F) or as other rheumatic diseases. Results. We found: 1) significantly decreased bone mineral density (BMD) of the whole hand, in the rheumatoid arthritis group versus the other rheumatic diseases group, at 6 and 12 months (P < 0.05); 2) no significant decrease of bone mineral density (BMD) in other areas in the rheumatoid arthritis group; 3) no significant change of ultrasounds in either group; and 4) no significant correlation between the decrease of BMD in the rheumatoid arthritis group and clinical, biological or radiologic parameters, except for IFN, whose production in whole blood cell culture was lower at entry in the rheumatoid arthritis group. Conclusion. DEXA bone assessment in rheumatoid arthritis was able to detect bone loss in the whole hand at 6 months. (C) 2001 Editions scientifiques et medicales Elsevier SAS.